Literature DB >> 22811505

Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward.

Zubin J Eapen1, W H Wilson Tang, G Michael Felker, Adrian F Hernandez, Kenneth W Mahaffey, A Michael Lincoff, Matthew T Roe.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22811505     DOI： 10.1161/CIRCOUTCOMES.112.966150

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  23 in total

1.  Association between mild thyroid dysfunction and clinical outcome in acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Qian Cao; Yundi Jiao; Tongtong Yu; Zhaoqing Sun
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

Review 2.  An emerging role for the miR-26 family in cardiovascular disease.

Authors:  Basak Icli; Pranav Dorbala; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2014-06-12       Impact factor: 6.677

Review 3.  The NLRP3 inflammasome in acute myocardial infarction.

Authors:  Stefano Toldo; Antonio Abbate
Journal:  Nat Rev Cardiol       Date:  2017-11-16       Impact factor: 32.419

4.  Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial Infarction.

Authors:  Marco Giuseppe Del Buono; Juan Ignacio Damonte; Juan Guido Chiabrando; Roshanak Markley; Jeremy Turlington; Cory R Trankle; Le Kang; Giuseppe Biondi-Zoccai; Benjamin W Van Tassell; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

5.  Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.

Authors:  Antonio Abbate; George F Wohlford; Marco Giuseppe Del Buono; Juan Guido Chiabrando; Roshanak Markley; Jeremy Turlington; Dinesh Kadariya; Cory R Trankle; Giuseppe Biondi-Zoccai; Michael J Lipinski; Benjamin W Van Tassell
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2022-08-11

6.  Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.

Authors:  Benjamin W Van Tassell; Michael J Lipinski; Darryn Appleton; Charlotte S Roberts; Michael C Kontos; Nayef Abouzaki; Ryan Melchior; George Mueller; James Garnett; Justin Canada; Salvatore Carbone; Leo F Buckley; George Wohlford; Dinesh Kadariya; Cory R Trankle; Claudia Oddi Erdle; Robin Sculthorpe; Laura Puckett; Christine DeWilde; Keyur Shah; Dominick J Angiolillo; George Vetrovec; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate
Journal:  Clin Cardiol       Date:  2018-08-17       Impact factor: 2.882

7.  Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.

Authors:  Nayef Antar Abouzaki; Sanah Christopher; Cory Trankle; Benjamin Wallace Van Tassell; Salvatore Carbone; Adolfo Gabriele Mauro; Leo Buckley; Stefano Toldo; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2018-06       Impact factor: 3.105

8.  Myeloid interleukin-4 receptor α is essential in postmyocardial infarction healing by regulating inflammation and fibrotic remodeling.

Authors:  Jianrui Song; Ryan A Frieler; Steven E Whitesall; Yutein Chung; Thomas M Vigil; Lindsey A Muir; Jun Ma; Frank Brombacher; Sascha N Goonewardena; Carey N Lumeng; Daniel R Goldstein; Richard M Mortensen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-11-08       Impact factor: 4.733

9.  Remote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trial.

Authors:  António Gaspar; Miguel Álvares Pereira; Pedro Azevedo; André Lourenço; Jorge Marques; Adelino Leite-Moreira
Journal:  Trials       Date:  2015-09-08       Impact factor: 2.279

10.  miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTEN.

Authors:  Jiahong Xu; Yu Tang; Yihua Bei; Shengguang Ding; Lin Che; Jianhua Yao; Hongbao Wang; Dongchao Lv; Junjie Xiao
Journal:  Oncotarget       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.